Loading organizations...
§ Private Profile · Saint Etienne, Rhone-Alpes, France
Medtech company developing ophthalmic surgical devices for ophthalmology, focused on anterior segment surgeries and cataract procedures.
Keranova is a French medtech company based in Saint-Etienne, Auvergne-Rhône-Alpes, that develops innovative medical lasers and surgical equipment for ophthalmology, focusing on anterior segment surgeries such as cataract procedures. Their ultra-fast femto laser technology enables photoemulsification for cataract removal, aiming to improve accuracy and speed in surgical outcomes. The company has raised a total of $31.06 million in funding, including a $26.51 million Series B round, and employs between 21 and 50 individuals, with an estimated annual revenue of $1.2 million. Lead investors include Mérieux Equity Partners and Supernova Invest, alongside participation from Financière Arbevel and Bpifrance. Keranova was founded in 2015 by Fabrice Romano, Aurélien Bernard, and six other co-founders. Its business model centers on venture-funded medtech company raising capital through equity financing rounds to develop and commercialize ophthalmic surgical devices.
Keranova has raised $31.1M across 2 funding rounds.
Keranova has raised $31.1M in total across 2 funding rounds.
Keranova has raised $31.1M across 2 funding rounds. Most recently, it raised $26.5M Other Equity in September 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 10, 2019 | $26.5M Venture Round | — | Financière Arbevel, Valerie Calenda, Supernova Invest, Philippe Tourrette | Announced |
| Apr 11, 2016 | $4.6M Series A | CEA Investissement, Mriux Dveloppement | Bpifrance | Announced |
Keranova has raised $31.1M in total across 2 funding rounds.
Keranova's investors include Financière Arbevel, Valerie Calenda, Supernova Invest, Philippe Tourrette, CEA Investissement, Mriux Dveloppement, Bpifrance.